These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 25675297

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. N-acetylglucosaminyltransferase V confers hepatoma cells with resistance to anoikis through EGFR/PAK1 activation.
    Liu J, Liu H, Zhang W, Wu Q, Liu W, Liu Y, Pan D, Xu J, Gu J.
    Glycobiology; 2013 Sep; 23(9):1097-109. PubMed ID: 23811795
    [Abstract] [Full Text] [Related]

  • 4. Klotho endows hepatoma cells with resistance to anoikis via VEGFR2/PAK1 activation in hepatocellular carcinoma.
    Chen L, Liu H, Liu J, Zhu Y, Xu L, He H, Zhang H, Wang S, Wu Q, Liu W, Liu Y, Pan D, Ren S, Xu J, Gu J.
    PLoS One; 2013 Sep; 8(3):e58413. PubMed ID: 23516476
    [Abstract] [Full Text] [Related]

  • 5. Sunitinib induces cellular senescence via p53/Dec1 activation in renal cell carcinoma cells.
    Zhu Y, Xu L, Zhang J, Hu X, Liu Y, Yin H, Lv T, Zhang H, Liu L, An H, Liu H, Xu J, Lin Z.
    Cancer Sci; 2013 Aug; 104(8):1052-61. PubMed ID: 23578198
    [Abstract] [Full Text] [Related]

  • 6. Molecular mechanism mediating cytotoxic activity of axitinib in sunitinib-resistant human renal cell carcinoma cells.
    Miyazaki A, Miyake H, Fujisawa M.
    Clin Transl Oncol; 2016 Sep; 18(9):893-900. PubMed ID: 26597115
    [Abstract] [Full Text] [Related]

  • 7. PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21.
    Wang Y, Gu X, Li W, Zhang Q, Zhang C.
    J Dermatol Sci; 2018 Apr; 90(1):60-67. PubMed ID: 29307600
    [Abstract] [Full Text] [Related]

  • 8. Decreased apoptosis repressor with caspase recruitment domain confers resistance to sunitinib in renal cell carcinoma through alternate angiogenesis pathways.
    Gobe GC, Ng KL, Small DM, Vesey DA, Johnson DW, Samaratunga H, Oliver K, Wood S, Barclay JL, Rajandram R, Li L, Morais C.
    Biochem Biophys Res Commun; 2016 Apr 22; 473(1):47-53. PubMed ID: 26995091
    [Abstract] [Full Text] [Related]

  • 9. Modulation of p21-activated kinase 1 alters the behavior of renal cell carcinoma.
    O'Sullivan GC, Tangney M, Casey G, Ambrose M, Houston A, Barry OP.
    Int J Cancer; 2007 Nov 01; 121(9):1930-1940. PubMed ID: 17621631
    [Abstract] [Full Text] [Related]

  • 10. NGAL can alternately mediate sunitinib resistance in renal cell carcinoma.
    Yu DS, Wu CL, Ping SY, Huang YL, Shen KH.
    J Urol; 2014 Aug 01; 192(2):559-66. PubMed ID: 24423438
    [Abstract] [Full Text] [Related]

  • 11. Antitumor effect of sunitinib against skeletal metastatic renal cell carcinoma through inhibition of osteoclast function.
    Maita S, Yuasa T, Tsuchiya N, Mitobe Y, Narita S, Horikawa Y, Hatake K, Fukui I, Kimura S, Maekawa T, Habuchi T.
    Int J Cancer; 2012 Feb 01; 130(3):677-84. PubMed ID: 21387300
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of PAK1 alleviates cerulein-induced acute pancreatitis via p38 and NF-κB pathways.
    Zhu M, Xu Y, Zhang W, Gu T, Wang D.
    Biosci Rep; 2019 Mar 29; 39(3):. PubMed ID: 30718368
    [Abstract] [Full Text] [Related]

  • 13. Downregulation of p21-activated kinase-1 inhibits the growth of gastric cancer cells involving cyclin B1.
    Liu F, Li X, Wang C, Cai X, Du Z, Xu H, Li F.
    Int J Cancer; 2009 Dec 01; 125(11):2511-9. PubMed ID: 19610058
    [Abstract] [Full Text] [Related]

  • 14. Induction of epithelial-mesenchymal transition via activation of epidermal growth factor receptor contributes to sunitinib resistance in human renal cell carcinoma cell lines.
    Mizumoto A, Yamamoto K, Nakayama Y, Takara K, Nakagawa T, Hirano T, Hirai M.
    J Pharmacol Exp Ther; 2015 Nov 01; 355(2):152-8. PubMed ID: 26306766
    [Abstract] [Full Text] [Related]

  • 15. Adrenomedullin blockade suppresses sunitinib-resistant renal cell carcinoma growth by targeting the ERK/MAPK pathway.
    Gao Y, Li J, Qiao N, Meng Q, Zhang M, Wang X, Jia J, Yang S, Qu C, Li W, Wang D.
    Oncotarget; 2016 Sep 27; 7(39):63374-63387. PubMed ID: 27556517
    [Abstract] [Full Text] [Related]

  • 16. Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-kappaB.
    Oka D, Nishimura K, Shiba M, Nakai Y, Arai Y, Nakayama M, Takayama H, Inoue H, Okuyama A, Nonomura N.
    Int J Cancer; 2007 Jun 15; 120(12):2576-81. PubMed ID: 17290398
    [Abstract] [Full Text] [Related]

  • 17. Identification of TGF-β-activated kinase 1 as a possible novel target for renal cell carcinoma intervention.
    Meng F, Li Y, Tian X, Fu L, Yin Y, Sui C, Ma P, Jiang Y.
    Biochem Biophys Res Commun; 2014 Oct 10; 453(1):106-11. PubMed ID: 25261726
    [Abstract] [Full Text] [Related]

  • 18. The convergent roles of NF-κB and ER stress in sunitinib-mediated expression of pro-tumorigenic cytokines and refractory phenotype in renal cell carcinoma.
    Makhov P, Naito S, Haifler M, Kutikov A, Boumber Y, Uzzo RG, Kolenko VM.
    Cell Death Dis; 2018 Mar 07; 9(3):374. PubMed ID: 29515108
    [Abstract] [Full Text] [Related]

  • 19. Autotaxin-lysophosphatidic acid signaling axis mediates tumorigenesis and development of acquired resistance to sunitinib in renal cell carcinoma.
    Su SC, Hu X, Kenney PA, Merrill MM, Babaian KN, Zhang XY, Maity T, Yang SF, Lin X, Wood CG.
    Clin Cancer Res; 2013 Dec 01; 19(23):6461-72. PubMed ID: 24122794
    [Abstract] [Full Text] [Related]

  • 20. PRKX, TTBK2 and RSK4 expression causes Sunitinib resistance in kidney carcinoma- and melanoma-cell lines.
    Bender C, Ullrich A.
    Int J Cancer; 2012 Jul 15; 131(2):E45-55. PubMed ID: 22020623
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.